Brilinta
/
Brilinta (ticagrelor) is an antiplatelet medication used to reduce the risk of cardiovascular events in patients with acute coronary syndrome or a history of heart attack. It is taken as an oral tablet and is available by prescription only. Patients are advised to inform their healthcare provider of any bleeding disorders, as Brilinta can increase the risk of bleeding. Also, it should not be used in patients with a history of intracranial hemorrhage or active bleeding conditions.
What is Brilinta
Brilinta is a medication that contains the active ingredient ticagrelor. It is primarily used to reduce the risk of cardiovascular events such as heart attack and stroke in patients with acute coronary syndrome or a history of myocardial infarction. The drug works by inhibiting platelet aggregation, which helps prevent blood clots from forming. Brilinta is often used in combination with aspirin for enhanced efficacy. There are other antiplatelet agents available, such as clopidogrel and prasugrel, which serve similar purposes but have different mechanisms of action and dosing regimens. The use of Brilinta should be guided by a healthcare professional based on individual patient needs.
25
commonly-prescribed
medication.